Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa study of laparoscopic allogeneic adipose-derived mesenchymal stem cells for inflammatory Crohn's disease stenosis
2021-006068-26Phase 2Active
- Sponsor
- Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
- Start
- Mar 2022
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of CSCC_ASC in Crohn's disease, sponsored by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz. Primary endpoint: Complications during anesthesia. Started Mar 2022; status: active.
02
Drugs
CSCC_ASC
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2021-006068-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-006068-26.